Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20,907,188
-
Total 13F shares
-
7,555,380
-
Share change
-
+7,555,380
-
Total reported value
-
$168,332,336
-
Put/Call ratio
-
2.8%
-
Price per share
-
$22.28
-
Number of holders
-
57
-
Value change
-
+$168,332,336
-
Number of buys
-
57
Institutional Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q4 2023
As of 31 Dec 2023,
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,555,380 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Verition Fund Management LLC, Point72 Asset Management, L.P., PFM Health Sciences, LP, Cormorant Asset Management, LP, VANGUARD GROUP INC, VR Adviser, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Velan Capital Investment Management LP, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.